Mindray and Edwards Lifesciences Integrate FloTrac™ Sensor for Bedside Monitoring
Friday, October 13, 2023
Mindray, a leading global healthcare solutions and technology provider specializing in ultrasound, patient monitoring, and anesthesia, has announced a significant development in their collaboration with Edwards Lifesciences, a worldwide pioneer in pioneering medical advancements for structural heart disease and the monitoring of critical care. This milestone represents a groundbreaking achievement where Mindray's BeneVision N-Series becomes the first patient monitoring system to seamlessly integrate Edwards' FloTrac™ sensor for hemodynamic monitoring within the North American market.
This partnership highlights the commitment of both companies to advance patient care by delivering comprehensive monitoring solutions. These solutions empower healthcare professionals with trusted and evidence-based technology to address the acute care needs of hospitals while improving patient safety.
Hemodynamically unstable patients require continuous monitoring of pressure and flow parameters to guide appropriate treatment. Mindray's BeneVision N-Series Patient Monitors combine the advanced hemodynamic parameters of the FloTrac™ sensor with other vital sign parameters. This integration provides critical care providers with deeper insights into their patients' physiological status.
Edwards' FloTrac™ sensor technology extends the capabilities of the N-Series to monitor patients' hemodynamic conditions effectively. It enables healthcare professionals to take proactive measures to prevent patient deterioration and implement individualized fluid management, especially in surgical and acute care settings. This collaboration exemplifies the dedication of both companies to enhance clinical decision-making, boost productivity, and ultimately advance patient care.